357 related articles for article (PubMed ID: 17993954)
1. In vitro effect of activated recombinant factor VII (rFVIIa) on coagulation properties of human blood at hypothermic temperatures.
Kheirabadi BS; Delgado AV; Dubick MA; Scherer MR; Fedyk CG; Holcomb JB; Pusateri AE
J Trauma; 2007 Nov; 63(5):1079-86. PubMed ID: 17993954
[TBL] [Abstract][Full Text] [Related]
2. Effect of hemodilution on coagulation and recombinant factor VIIa efficacy in human blood in vitro.
Darlington DN; Delgado AV; Kheirabadi BS; Fedyk CG; Scherer MR; Pusateri AE; Wade CE; Cap AP; Holcomb JB; Dubick MA
J Trauma; 2011 Nov; 71(5):1152-63. PubMed ID: 21610535
[TBL] [Abstract][Full Text] [Related]
3. Effects of increasing doses of activated recombinant factor VII on haemostatic parameters in swine.
Pusateri AE; Ryan KL; Delgado AV; Martinez RS; Uscilowicz JM; Cortez DS; Martinowitz U
Thromb Haemost; 2005 Feb; 93(2):275-83. PubMed ID: 15711743
[TBL] [Abstract][Full Text] [Related]
4. Hypothermia and acidosis synergistically impair coagulation in human whole blood.
Dirkmann D; Hanke AA; Görlinger K; Peters J
Anesth Analg; 2008 Jun; 106(6):1627-32. PubMed ID: 18499589
[TBL] [Abstract][Full Text] [Related]
5. Differential clot stabilising effects of rFVIIa and rFXIII-A2 in whole blood from thrombocytopenic patients and healthy volunteers.
Johansson PI; Jacobsen N; Viuff D; Olsen EH; Rojkjaer R; Andersen S; Petersen LC; Kjalke M
Br J Haematol; 2008 Nov; 143(4):559-69. PubMed ID: 18950467
[TBL] [Abstract][Full Text] [Related]
6. Overcoming delayed in-vitro response to rFVIIa: effects of rFVIIa and rFVIIa analogue (vatreptacog alfa) concentration escalation in whole blood assays.
Brophy DF; Martin EJ; Barrett JC; Nolte ME; Kuhn JG; Hedner U; Ezban M
Blood Coagul Fibrinolysis; 2011 Sep; 22(6):541-6. PubMed ID: 21681082
[TBL] [Abstract][Full Text] [Related]
7. Factor VIIa analog has marked effects on platelet function and clot kinetics in blood from patients with hemophilia A.
Brophy DF; Martin EJ; Nolte ME; Kuhn JG; Barrett JC; Ezban M
Blood Coagul Fibrinolysis; 2010 Sep; 21(6):539-46. PubMed ID: 20581663
[TBL] [Abstract][Full Text] [Related]
8. Effects of recombinant activated factor VII on coagulation measured by thromboelastography in liver transplantation.
Hendriks HG; Meijer K; de Wolf JT; Porte RJ; Klompmaker IJ; Lip H; Slooff MJ; van der Meer J
Blood Coagul Fibrinolysis; 2002 Jun; 13(4):309-13. PubMed ID: 12032396
[TBL] [Abstract][Full Text] [Related]
9. Thrombelastography is better than PT, aPTT, and activated clotting time in detecting clinically relevant clotting abnormalities after hypothermia, hemorrhagic shock and resuscitation in pigs.
Martini WZ; Cortez DS; Dubick MA; Park MS; Holcomb JB
J Trauma; 2008 Sep; 65(3):535-43. PubMed ID: 18784565
[TBL] [Abstract][Full Text] [Related]
10. Intravenous rFVIIa administered for hemorrhage control in hypothermic coagulopathic swine with grade V liver injuries.
Martinowitz U; Holcomb JB; Pusateri AE; Stein M; Onaca N; Freidman M; Macaitis JM; Castel D; Hedner U; Hess JR
J Trauma; 2001 Apr; 50(4):721-9. PubMed ID: 11303171
[TBL] [Abstract][Full Text] [Related]
11. A direct thrombin inhibitor studied by dynamic whole blood clot formation. Haemostatic response to ex-vivo addition of recombinant factor VIIa or activated prothrombin complex concentrate.
Sørensen B; Ingerslev J
Thromb Haemost; 2006 Oct; 96(4):446-53. PubMed ID: 17003921
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of rFVIIa (NovoSeven) in Glanzmann patients with thromboelastogram.
Lak M; Scharling B; Blemings A; Sharifian R; Maleki Z; Daraee A; Arjmand AR; Hedner U
Haemophilia; 2008 Jan; 14(1):103-10. PubMed ID: 18070065
[TBL] [Abstract][Full Text] [Related]
13. Factor VIIa analogue (V158D/E296V/M298Q-FVIIa) normalises clot formation in whole blood from patients with severe haemophilia A.
Sørensen B; Persson E; Ingerslev J
Br J Haematol; 2007 Apr; 137(2):158-65. PubMed ID: 17391496
[TBL] [Abstract][Full Text] [Related]
14. The role of platelets and recombinant factor VIIa on thrombin generation, platelet activation and clot formation.
Gerotziafas GT; Chakroun T; Depasse F; Arzoglou P; Samama MM; Elalamy I
Thromb Haemost; 2004 May; 91(5):977-85. PubMed ID: 15116259
[TBL] [Abstract][Full Text] [Related]
15. Citrate artificially masks the haemostatic effect of recombinant factor VIIa in dilutional coagulopathy.
Fenger-Eriksen C; Ingerslev J; Tønnesen E; Sørensen B
Ann Hematol; 2009 Mar; 88(3):255-60. PubMed ID: 18696068
[TBL] [Abstract][Full Text] [Related]
16. Recombinant Factor VIIa Reduces Bleeding after Blunt Liver Injury in a Pig Model of Dilutional Coagulopathy under Severe Hypothermia.
Spronk HM; Braunschweig T; Rossaint R; Wüst DC; van Oerle R; Lauritzen B; Tolba R; Grottke O
PLoS One; 2015; 10(6):e0113979. PubMed ID: 26098426
[TBL] [Abstract][Full Text] [Related]
17. Improved clot formation by combined administration of activated factor VII (NovoSeven) and fibrinogen (Haemocomplettan P).
Tanaka KA; Taketomi T; Szlam F; Calatzis A; Levy JH
Anesth Analg; 2008 Mar; 106(3):732-8, table of contents. PubMed ID: 18292410
[TBL] [Abstract][Full Text] [Related]
18. Combination of recombinant factor VIIa and fibrinogen corrects clot formation in primary immune thrombocytopenia at very low platelet counts.
Larsen OH; Stentoft J; Radia D; Ingerslev J; Sørensen B
Br J Haematol; 2013 Jan; 160(2):228-36. PubMed ID: 23151086
[TBL] [Abstract][Full Text] [Related]
19. Wide temperature range testing with ROTEM coagulation analyses.
Kander T; Brokopp J; Friberg H; Schött U
Ther Hypothermia Temp Manag; 2014 Sep; 4(3):125-30. PubMed ID: 24933403
[TBL] [Abstract][Full Text] [Related]
20. Recombinant factor VIIa and fibrinogen display additive effect during in vitro haemodilution with crystalloids.
Fenger-Eriksen C; Tønnesen E; Ingerslev J; Sørensen B
Acta Anaesthesiol Scand; 2009 Mar; 53(3):332-8. PubMed ID: 19243319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
